Atlas Trials

Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)

Clinical trial NCT05106413 · TERMINATED

Trial details

NCT number
NCT05106413
Sponsor
Sonova AG
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hearing Loss
Start date
2021-10-26
Primary completion
2022-03-14
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.